<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02705833</url>
  </required_header>
  <id_info>
    <org_study_id>CA209-551</org_study_id>
    <nct_id>NCT02705833</nct_id>
  </id_info>
  <brief_title>Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada</brief_title>
  <official_title>Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bristol-Myers Squibb</source>
  <brief_summary>
    <textblock>
      The primary objective of the study is to characterize the medical management of squamous cell
      carcinoma head and neck (SCCHN) patients diagnosed with recurrent/metastatic (R/M) disease
      (between 01July2013 and 30 June 2014) in the real-world setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">December 6, 2016</completion_date>
  <primary_completion_date type="Actual">December 6, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Best Therapy Response defined as Complete Response (CR), Partial Response (PR), Stable Disease (SD) or Progressive Disease (PD) based on physician's assessment for each therapy regimen</measure>
    <time_frame>approximately 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Survival(OS) of patients with an Index diagnosis of R/M SCCHN</measure>
    <time_frame>approximately 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Progression-Free Survival(PFS) of patients with an Index diagnosis of R/M SCCHN</measure>
    <time_frame>approximately 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Recurrent-Free Survival(RFS) of patients with an Index diagnosis of R/M SCCHN</measure>
    <time_frame>approximately 12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Response Rate(ORR) of patients with an Index diagnosis of R/M SCCHN</measure>
    <time_frame>approximately 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of R/M SCCHN-related health care resource use</measure>
    <time_frame>approximately 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment selection conditional on patient demographics, comorbidities, disease severity, and other characteristics as well as clinician demographics, therapy preferences, and other characteristics</measure>
    <time_frame>approximately 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best Therapy Response conditional on patient demographics, comorbidities, disease severity, treatment received, and other characteristics</measure>
    <time_frame>approximately 12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">591</enrollment>
  <condition>Head and Neck Cancer</condition>
  <arm_group>
    <arm_group_label>Population with R/M SCCHN</arm_group_label>
    <description>Recurrent/Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN) patients diagnosed between 01July2013 and 30June2014, alive or deceased, at the time of data collection</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with R/M SCCHN between 01July2013 and 30June2014
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient (18 years old or older) with a confirmed diagnosis or R/M head and neck,
             may be living or deceased at time of enrollment in the study

          -  Diagnosis of R/M head and neck cancer between 01July2013 and 30June2014 (study index
             period)

        Exclusion Criteria:

          -  If female patient, pregnant or lactating between 01July2013 and 30June2014

          -  Enrolled in cancer treatment-clinical trials since diagnosis of R/M head and neck
             cancer during the study index period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bristol-Myers Squibb</last_name>
    <role>Study Director</role>
    <affiliation>Bristol-Myers Squibb</affiliation>
  </overall_official>
  <link>
    <url>http://www.fda.gov/MEDWATCH/safety.htm</url>
    <description>FDA Safety Alerts and Recalls</description>
  </link>
  <link>
    <url>http://www.bms.com/clinical_trials/Pages/Investigator_inquiry_form.aspx</url>
    <description>Investigator Inquiry Form</description>
  </link>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2016</study_first_posted>
  <last_update_submitted>April 21, 2017</last_update_submitted>
  <last_update_submitted_qc>April 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

